Penn Brain Science, Translation, Innovation, and Modulation Center
The Penn Brain Science, Translation, Innovation, and Modulation (brainSTIM) Center brings together a team of leading neuroscientists, neurologists, psychiatrists, psychologists, and engineers the University of Pennsylvania who use groundbreaking neuromodulation techniques to research, repair, and enhance human brain function. In order to accomplish this goal, the brainSTIM Center has created a framework for cooperation that cuts across departmental and institutional boundaries. The center promotes intellectually rewarding, productive, and novel scientific collaborations in the field of neuromodulation by leveraging critical skills and resources, creating unique opportunities for growth, innovation, and substainability for neuromodulation research.
The Latest at brainSTIM
brainSTIM Friends and Faculty,
In the past year, we have all seen the Penn brainSTIM Center launch and grow during what turned out to be a challenging but fruitful time. This is thanks to the hard work of our faculty, staff, and advisors. We would like to extend our gratitude for everyone's support and invite you to look back on brainSTIM's development and learn more about the Center and its members. To read our 'brainSTIM 2020 Year in Review', click below.
More From Twitter
Monday, January 4, 2021
Director Roy Hamilton was named as one of Cell Community of Scholars' 1000 inspiring black scientists in America! Check out the full list here: http://crosstalk.cell.com/blog/1000-inspiring-black-scientists-in-america
Thursday, December 24, 2020
Wishing everyone a happy and healthy holiday season from all of us at here at brainSTIM!
Tuesday, December 22, 2020
brainSTIM would like to congratulate center scientist Dr. Kelly Sloane for receiving the CTSA KL2 Mentored Career Development Award from the Institute for Translational Medicine and Therapeutics! This award will enable Dr. Sloane to train in Penn's Master of Science in Translational Research program, as well as continue her work regarding the application of tDCS as an intervention for cognitive impairment in subacute stage stroke survivors.